Table 4 Frequency and percentage of respondents with TTO utility values less than 0.95 1 (Studies 2 and 3)
Health states | Caregivers | Non-caregivers | p-value2 |
|---|---|---|---|
Study 2 (Caregivers, n = 47, Non-caregivers, n = 111) | |||
A. Adult ADHD, receiving treatment, responder | 24 (51.1%) | 65 (58.6%) | 0.39 |
B. Adult ADHD, receiving treatment, non-responder | 33 (70.2%) | 86 (77.5%) | 0.33 |
C. Adult ADHD, untreated | 34 (72.3%) | 88 (79.3%) | 0.34 |
Study 3 (Caregivers, n = 29, Non-caregivers, n = 97) | |||
A. Basic HS (stable schizophrenia, no adverse events) | 20 (69.0%) | 73 (75.3%) | 0.50 |
B. Basic HS + metabolic syndrome | 22 (75.9%) | 86 (88.7%) | 0.08 |
C. Basic HS + weight gain | 23 (79.3%) | 78 (80.4%) | 0.90 |
D. Basic HS + diabetes | 21 (72.4%) | 83 (85.6%) | 0.10 |
E. Basic HS + hyperlipidemia | 21 (72.4%) | 83 (85.6%) | 0.10 |
F. Basic HS + male sexual dysfunction | 10 (83.3%) | 39 (81.3%) | 0.87 |
G. Basic HS + female sexual dysfunction | 13 (76.5%) | 41 (83.7%) | 0.51 |
H. Basic HS + male increased prolactin levels | 10 (83.3%) | 40 (83.3%) | 1.00 |
I. Basic HS + female increased prolactin levels | 12 (70.6%) | 43 (87.8%) | 0.10 |
J. Basic HS + akathisia | 22 (75.9%) | 84 (86.6%) | 0.17 |
K. Basic HS + tardive dyskinesia | 24 (82.8%) | 90 (92.8%) | 0.11 |
L. Basic HS + other extrapyramidal symptoms | 23 (79.3%) | 91 (93.8%) | 0.02 |
M. Basic HS + insomnia | 20 (69.0%) | 83 (85.6%) | 0.04 |
N. Basic HS + somnolence | 21 (72.4%) | 83 (85.6%) | 0.10 |
O. Basic HS + nausea | 20 (69.0%) | 80 (82.5%) | 0.11 |
P. Basic HS + vomiting | 21 (72.4%) | 81 (83.5%) | 0.18 |